We evaluated the effects of VPA on HCC HTB-52, HepG2 cells, and normal liver THLE2 cells, along with other Notch inhibitors such as DBZ, DAPT, and other HDAC inhibitors such as TSA and SAHA, done at their customary concentrations (Figure 6). This evidence concerns the gene HDAC9 and hepatocellular carcinoma.